Optimizing the discovery and assessment of therapeutic targets in heart failure with preserved ejection fraction
Abstract There is an urgent need for models that faithfully replicate heart failure with preserved ejection fraction (HFpEF), now recognized as the most common form of heart failure in the world. In vitro approaches have several shortcomings, most notably the immature nature of stem cell‐derived hum...
Main Authors: | Gabrielle Fusco‐Allison, Desmond K. Li, Benjamin Hunter, Dan Jackson, Paul G. Bannon, Sean Lal, John F. O'Sullivan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13504 |
Similar Items
-
Heart Failure with Preserved Ejection Fraction (HFpEF): A Case Report
by: Amanda Halimi, et al.
Published: (2021-09-01) -
Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
by: Satyam Sarma, et al.
Published: (2020-11-01) -
Heart Failure With Preserved Ejection Fraction and Obesity
by: Arjun Sinha, MD, et al.
Published: (2020-01-01) -
Murine Models of Heart Failure With Preserved Ejection Fraction
by: Maria Valero-Muñoz, PhD, et al.
Published: (2017-12-01) -
Approach to the Treatment of Heart Failure With Preserved Ejection Fraction and Mid-Range Ejection Fraction
by: Ewa A Jankowska, et al.
Published: (2017-01-01)